A detailed history of Clearstead Advisors, LLC transactions in Omnicell, Inc stock. As of the latest transaction made, Clearstead Advisors, LLC holds 70 shares of OMCL stock, worth $2,797. This represents 0.0% of its overall portfolio holdings.

Number of Shares
70
Holding current value
$2,797
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 10, 2025

BUY
$39.5 - $53.05 $2,765 - $3,713
70 New
70 $3,000
Q2 2024

Aug 09, 2024

BUY
$26.22 - $32.65 $6,790 - $8,456
259 New
259 $7,000

Others Institutions Holding OMCL

About OMNICELL, Inc


  • Ticker OMCL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 44,288,800
  • Market Cap $1.77B
  • Description
  • Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensi...
More about OMCL
Track This Portfolio

Track Clearstead Advisors, LLC Portfolio

Follow Clearstead Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearstead Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearstead Advisors, LLC with notifications on news.